CLINICAL_TRIALS
trial_result
· 2025-02-24
Clinical Trial Update: A Vasoconstriction Study With LEO 90100 [Phase 1]
Summary
Phase 1 trial of LEO 90100 for psoriasis vulgaris has completed, reporting results from a vasoconstriction study.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: LEO Pharma | Conditions: Psoriasis Vulgaris | Phase 1 | Status: COMPLETED